Minnesota Cancer Clinical Trials Network Funds Home-Based Cancer Care Study in 2023 Grant Program
The Minnesota Cancer Clinical Trials Network (MNCCTN) is happy to announce the funding of a study, “Evaluating the Time Burdens of Home-Based Cancer Care,” as part of the 2023-2024 MNCCTN Grant Program. The study is led by Arjun Gupta, MD, gastrointestinal oncologist and health services researcher with the Masonic Cancer Center.
Dr. Gupta's study was awarded in the Discovery & Planning Grant category. The Discovery & Planning Grant is open to MNCCTN partners only, research or clinical. The aim of this award is to develop a community-driven research concept by partnering with an identified community to learn about their most pressing cancer-related needs, as well as working collaboratively with the community to develop potential strategies to address those needs. The completion of the project should result in a collaboratively developed research concept that could be pilot tested with the identified community. The project received $15,000 in funding for this award. Dr. Gupta will work with the MNCCTN HUB on development and implementation of the project over the next year.
Dr. Gupta's study is a collaboration with M Health Fairview. M Health Fairview is the clinical partner of the Masonic Cancer Center, as well as an MNCCTN Partner with three sites in Greater Minnesota in Princeton, Hibbing, and Grand Rapids. Dr. Gupta's study will evaluate time burdens of home-based cancer care for M Health Fairview patients, with a long-term goal of minimizing time burdens of cancer care.
The MNCCTN Grant Program, first launched in 2021, offers several different award options regularly. The program aims to develop research that addresses the unique cancer burden of Minnesotans, encourage community-driven research, increase capacity of MNCCTN sites, develop sustainable collaborations between community-based organizations and academic researchers, and expand the culture of research across Minnesota. To learn more about the program and previously funded projects, visit the MNCCTN Grant Program webpage.
The Minnesota Cancer Clinical Trials Network (MNCCTN) is a cancer clinical trials network with locations across Minnesota. The network is funded by the Minnesota legislature as part of the University of Minnesota's MnDRIVE Program. Led by the Masonic Cancer Center, University of Minnesota, MNCCTN and its partner organizations aim to improve cancer outcomes for all Minnesotans through greater access to cancer clinical trials in prevention and treatment.